Abbott launches Xience Prime drug eluting stent in international markets

Abbott announced at the European Society of Cardiology Congress the widespread availability of its next-generation Xience Prime Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

The details can be read here.